Research suggests that kava has a reasonably consistent body of support for its relaxation and anxiolytic effects, with multiple reviews identifying it as one of the more evidence-backed complementary options for managing everyday stress and mild to generalized anxiety, and one 2004 systematic review of 108 treatments found kava had among the strongest support of any complementary approach for generalized anxiety specifically. Studies indicate that kava's calming properties likely stem from several neurochemical mechanisms, including activity at GABA receptors, reversible inhibition of MAO-B, and modulation of dopamine and serotonin levels in brain reward pathways, as suggested by in vitro and animal research. A large 2026 survey of U.S. adults found that 88% of past-year kava users rated it effective for relaxation and stress relief, and a 2020 pilot trial observed reduced cortisol levels following one week of kava use, though both findings carry methodological limitations inherent to self-report surveys and small pilot studies. The overall evidence base is notably heterogeneous in study type — leaning heavily on reviews, mechanistic studies, and observational data rather than large randomized controlled trials — and while the safety profile appears generally acceptable for healthy adults in moderate use, rat studies suggest dose-dependent liver toxicity that is meaningfully worsened by concurrent alcohol consumption, a caution that several reviewers have echoed.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| [Pharmacotherapy]. | Review | 1997 | Supports | 100 |
| Generalised anxiety disorder. | Systematic review | 2007 | Neutral | 95 |
| Anxiety, depression, and insomnia. | Review | 2002 | Supports | 90 |
| The role of N-terminal acetylation on biomolecular condensation | Other | 2025 | Neutral | 85 |
| Formulations of dietary supplements and herbal extracts for relaxation and an... | Review | 2009 | Supports | 85 |
| Relaxation drinks and their use in adolescents. | Review | 2011 | Mixed | 80 |
| A primer of complementary and alternative medicine commonly used by cancer pa... | Review | 2001 | Supports | 75 |
| Isolation and Identification of Constituents Exhibiting Antioxidant, Antibact... | Other | 2022 | Neutral | 70 |
| Effectiveness of complementary and self-help treatments for anxiety disorders. | Review | 2004 | Supports | 65 |
| Saccade and cognitive function in chronic kava users. | Other | 2003 | Neutral | 60 |
| Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methy... | Other | 1998 | Supports | 55 |
| Prevalence and use patterns of kava (Piper methysticum) in a US nationally re... | Other | 2026 | Supports | 50 |
| The Impact of One-week Dietary Supplementation with Kava on Biomarkers of Tob... | Other | 2020 | Supports | 45 |
| The sub-acute toxicity of kavalactone in rats: a study of the effect of oral ... | Other | 2023 | Neutral | 40 |
| Effect of kava extract and individual kavapyrones on neurotransmitter levels ... | Other | 1998 | Supports | 35 |
| Determination of kavalactones in dried kava (Piper methysticum) powder using ... | Other | 2006 | Neutral | 30 |